Stock Analysis, Dividends, Split History

HRTG / Heritage Insurance Holdings, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price15.01
Volume172,800.00
Market Cap ($M)388.98
Enterprise Value ($M)347.90
Book Value ($M)386.08
Book Value / Share14.53
Price / Book1.01
NCAV / Sharen/a
Price / NCAVn/a
Share Statistics
Common Shares Outstanding 26,560,004
Common Stock Shares Outstanding 25,885,004
Scoring Models
Piotroski F-Score3.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-0.00
Return on Assets (ROA)-0.00
Return on Equity (ROE)-0.00
Balance Sheet (mrq) ($M)
Assets1,990.90
Liabilities1,604.82
Quick Ration/a
Current Ration/a
Income Statement (mra) ($M)
Revenues406,623,000.00
Operating Income49.53
Net Income-1.12
Earnings Per Share Basic-0.04
Earnings Per Share Diluted-0.04
Cash Flow Statement (mra) ($M)
Cash From Operations7.57
Cash from Investing-7.24
Cash from Financing7.57
Identifiers and Descriptors
CUSIP42727J102
Central Index Key (CIK)1598665
Related CUSIPS
42727J952 42727J902

Split History

Stock splits are used by Heritage Insurance Holdings, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

Heritage Insurance Holdings' (HRTG) CEO Bruce Lucas on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Heritage Insurance Holdings, Inc. (NYSE:HRTG) Q1 2018 Earnings Conference Call May 8, 2018 8:30 AM ET (1-1)

Health Insurance (HIIQ) Soars Past 80% in a Year: Here's Why

2018-04-02 zacks
That Health Insurance Innovations, Inc. (HIIQ - Free Report) stock is favored by investors, is corroborated by its agreeable share price movement. Shares of the company have soared 80.6% in a year, outperforming its industry's increase of only 3.8% and the S&P 500 index’s rally of 14.5%. With a market capitalization of $478 million, average volume of shares traded in the last three months was 0.4 million. (16-0)

5 Reasons Why Travelers Stock Fits Your Portfolio to the Tee

2018-03-28 zacks
The Travelers Companies Inc. (TRV - Free Report) has seen the Zacks Consensus Estimate for 2018 and 2019 earnings being revised upward over the last 60 days. While current-year estimates moved 0.3% north, the consensus mark for 2019 was nudged up 0.4%. This upward estimate revision reflects analysts’ optimism in the stock. Notably, the company is a leading provider of property-casualty insurance for auto, home and business. (8-0)

Avoid ProAssurance (PRA), Check These Top 3 Insurers Instead

2018-03-27 zacks
ProAssurance Corporation (PRA - Free Report) has been recently witnessing downward revisions. The stock has seen the Zacks Consensus Estimate for 2018 earnings being revised 11% downward. For 2019, our consensus estimate has moved 1.6% south. (15-0)

6 Reasons Why You Should Hold AXIS Capital in Your Portfolio

2018-03-23 zacks
AXIS Capital Holdings Limited (AXS - Free Report) is a global provider of specialty lines insurance and treaty reinsurance. Shares of this Zacks Rank #3 (Hold) property and casualty insurer have rallied 12.8% year to date, outperforming the industry’s growth of 0.3%. (10-0)

CUSIP: 42727J102